Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Several factors influence credit card points accumulation. Learn what affects your rewards to enhance your earning potential.
16,561 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Two major travel stocks have caught the eye of billionaire activist investors. This article breaks down what could ha...
Investing in Nexpoint Residential (NXRT) hinges on understanding earnings beyond headline numbers. This guide breaks ...
Argentina presses ahead with sweeping reforms, betting on privatizations and tighter budgets. Investors are turning t...
Explore an investor-friendly view of Privia Health as it heads into 2025. This original analysis covers growth driver...
Rocket Lab is shaping the small-launch landscape, and the company’s 2025 earnings story matters for investors. This g...
AI's rapid growth in 2026 is real, but the panic around job loss and market collapse is overblown. This report explai...
Looking for a reliable income stream from stocks? This article examines why AbbVie may be the abbvie stock ultimate o...
Kensho Clean Power ETF (CNRG) surged 68% over the last year but fell 9% in February, as traders await a Fed signal th...
GitLab delivered solid revenue growth but offered modest profitability guidance, triggering a sharp stock move. This ...
February layoffs slowed to 48,307, down sharply from January and far below last year's level. Analysts warn volatilit...
With the Fed chair signaling a hawkish tilt, markets brace for higher-for-longer policy. History suggests the last ti...